Table 2.
Baseline characteristics of 278 women in trial of oral and vaginal lactobacillus for preventing post-antibiotic vulvovaginitis by treatment group. Values are numbers (percentages*) unless stated otherwise
|
Oral lactobacillus
|
Oral placebo
|
|||
|---|---|---|---|---|
| Characteristics | Vaginal lactobacillus (n=67) | Vaginal placebo (n=73) | Vaginal lactobacillus (n=70) | Vaginal placebo (n=68) |
| Demographic | ||||
| Mean (SD) age (years) | 35.8 (7.7) | 35.8 (8.4) | 32.7 (9.1) | 33.5 (8.3) |
| Single women | 20 (30) | 12 (17) | 24 (35) | 18 (27) |
| Completed tertiary education | 36 (54) | 41 (57) | 41 (59) | 39 (58) |
| Ever drinks alcohol | 58 (87) | 63 (88) | 52 (75) | 55 (82) |
| Income >$A1000/week | 27 (41) | 44 (65) | 31 (48) | 33 (51) |
| Risk factors | ||||
| Using oestrogen based drugs | 21 (31) | 17 (23) | 21 (30) | 22 (33) |
| Regular menstrual cycle | 50 (75) | 45 (63) | 47 (68) | 50 (75) |
| Prone to post-antibiotic vulvovaginitis (self assessed)† | 15 (22) | 17 (25) | 18 (27) | 22 (34) |
| Baseline vaginal swab positive for candida species | 16 (24) | 17 (23) | 17 (24) | 9 (13) |
| Taking narrow spectrum antibiotics | 20 (30) | 15 (21) | 15 (21) | 20 (29) |
*
Discrepancies in the percentages because of missing responses.
†
Responded “Often” or “Always” to question: “How often do you get thrush when taking antibiotics?”